CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatment. Read more about CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatment.
Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion. Read more about Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion.
Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation. Read more about Heart failure drug proscillaridin A targets MYC overexpressing leukemia through global loss of lysine acetylation.
CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells. Read more about CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells.
Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas. Read more about Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas.
Detection of E2A-PBX1 fusion transcripts in human non-small-cell lung cancer. Read more about Detection of E2A-PBX1 fusion transcripts in human non-small-cell lung cancer.
SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma. Read more about SMO expression level correlates with overall survival in patients with malignant pleural mesothelioma.
